Bio-Works Technologies AB (publ) (NGM:BIOWKS)

Sweden flag Sweden · Delayed Price · Currency is SEK
2.800
+0.060 (2.19%)
At close: Mar 4, 2026
76.10%
Market Cap 278.39M
Revenue (ttm) 63.11M
Net Income (ttm) -15.25M
Shares Out 99.42M
EPS (ttm) -0.18
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 39,251
Average Volume 121,074
Open 2.760
Previous Close 2.740
Day's Range 2.760 - 2.940
52-Week Range 0.950 - 3.570
Beta 1.04
RSI 46.93
Earnings Date Feb 20, 2026

About Bio-Works Technologies AB

Bio-Works Technologies AB (publ), together with its subsidiaries, engages in the manufactures and sale of chromatography resins for the purification of biopharmaceuticals in Sweden. The company offers affinity and activated resin, hydrophobic interaction chromatography (HIC) resins, GoBio Mini and GoBio prepacked columns, ion exchange chromatography (IEX) resin, immobilized metal-ion affinity chromatography (IMAC) resin, size exclusion chromatography (SEC) resins, HTPD formats, screening kits, and desalting columns; and WorkBeads chromatography... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2006
Employees 26
Stock Exchange Nordic Growth Market
Ticker Symbol BIOWKS
Full Company Profile

Financial Performance

In 2025, Bio-Works Technologies AB's revenue was 63.11 million, an increase of 107.01% compared to the previous year's 30.49 million. Losses were -15.25 million, -59.19% less than in 2024.

Financial Statements

News

There is no news available yet.